Shan Hu et al. demonstrated that the miR-200c knockdown provides considerable protective effects against AngII-induced cardiac hypertrophy in cardiomyocytes by targeting MLCK and blocking ROS production and apoptosis [18]. The gene discussed is MYLK3; the disease is cardiac hypertrophy.